Please use this identifier to cite or link to this item:
http://hdl.handle.net/1942/21898
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.advisor | MICHIELS, Luc | - |
dc.contributor.author | VANDEN BON, Natalie | - |
dc.date.accessioned | 2016-08-04T12:08:46Z | - |
dc.date.available | 2016-08-04T12:08:46Z | - |
dc.date.issued | 2014 | - |
dc.identifier.uri | http://hdl.handle.net/1942/21898 | - |
dc.description.abstract | A biosensor is an integrated device, combining a biological recognition element with a transducer. The transducer translates the recognition of target molecules into a quantifiable output signal. Since the first biosensor in 1962, a lot of different biosensor platforms are developed for a multitude of applications, but mostly for medical applications. Biosensors can be categorized by the type of recognition element, like enzymes, antibodies and DNA-molecules. Alternatively, biosensors can be classified based on the type of transduction principle. There are for example electrochemical, optical and piezoelectrical biosensors | - |
dc.description.abstract | Biosensoren zijn analytische apparaten die bestaan uit een laag van biologische herkenningsmoleculen gebonden aan een vaste drager, genaamd een transducer. Deze transducer vertaalt de herkenning van biologische doelwitmoleculen in een kwantificeerbaar uitleessignaal. Sinds de eerste biosensor in 1962 werden er verschillende biosensorplatformen ontwikkeld voor tal van uiteenlopende toepassingen. De meeste biosensoren werden echter ontwikkeld voor toepassingen binnen de klinische wereld. Biosensoren kunnen ingedeeld worden volgens het gebruikte type biologische herkenningsmolecule, zoals enzymen, antilichamen of DNA-moleculen. Biosensoren kunnen op alternatieve wijze ingedeeld worden via de gebruikte uitleesmethode. Zo bestaan er o.a. elektronische, optische en piezo-elektrische biosensoren. | - |
dc.language.iso | en | - |
dc.title | Clinical Relevance of NCD-based, Real-Time and Label-Free Sensor Platforms. A Focus on DNA SNP Mutation and Protein Biomarker Detection in Patient-Derived Samples | - |
dc.type | Theses and Dissertations | - |
local.format.pages | 182 | - |
local.bibliographicCitation.jcat | T1 | - |
local.type.refereed | Non-Refereed | - |
local.type.specified | Phd thesis | - |
item.fulltext | With Fulltext | - |
item.contributor | VANDEN BON, Natalie | - |
item.fullcitation | VANDEN BON, Natalie (2014) Clinical Relevance of NCD-based, Real-Time and Label-Free Sensor Platforms. A Focus on DNA SNP Mutation and Protein Biomarker Detection in Patient-Derived Samples. | - |
item.accessRights | Open Access | - |
Appears in Collections: | PhD theses Research publications |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Natalie Vanden Bon.pdf | 2.07 MB | Adobe PDF | View/Open |
Google ScholarTM
Check
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.